Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

A gene mutation in mice causes skin defects and early death.

Finasteride effectively reduces hair loss by decreasing androgen levels.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

The study found that the enzyme linked to acne is present in the same areas of both acne-affected and normal skin.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.